MedTrace Logo

Effect of Xenogeneic Collagen Matrix on the Peri-implant Tissues of Immediate Implants.

NCT04980313 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2021-07-28

No results posted yet for this study

Summary

The present clinical trial will try to demonstrate the efficacy of stable xenogeneic collagen matrix in maintaining the vestibular coronal soft tissue volume and the stabilization of mid-buccal margin position in immediate post-extraccion sockets compared with the use of autogenous connective tissue grafts.

Conditions

  • Xenograft Model

Interventions

DEVICE

Xenogenic collagen matrix

Use of xenogenic collagen matrix for the maintenance of buccal soft tissues around immediate dental implantes into extraction sockets.

DEVICE

Autogenous connective tissue graft

Use of connective tissue graft for the maintenance of buccal soft tissues around immediate dental implantes into extraction sockets.

Sponsors & Collaborators

  • Geistlich Pharma AG

    collaborator INDUSTRY

  • Universitat Internacional de Catalunya

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-27
Primary Completion
2023-04-30
Completion
2023-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04980313 on ClinicalTrials.gov